The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s direct to consumer DTC genetic testing market report forecasts the direct to consumer DTC genetic testing market size to grow to $2.81 Billion by 2027, with a CAGR (compound annual growth rate) of more than 15%.

Learn More On The Direct To Consumer DTC Genetic Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Direct To Consumer DTC Genetic Testing Market Size Forecast
The global direct to consumer DTC genetic testing market is expected to grow from $1.35 billion in 2022 to $1.58 billion in 2023 at a compound annual growth rate (CAGR) of 16.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global direct-to-consumer (DTC) genetic testing market size is expected to grow to $2.81 billion in 2027 at a CAGR of 15.5%.

North America held the largest direct to consumer DTC genetic testing market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Direct To Consumer DTC Genetic Testing Market Driver ­– Rise In The Prevalence Of Diseases And Disorders With Genetic Transmission Capabilities
According to MedlinePlus, a US-based online information service provided by the US National Library of Medicine, in 2021, syndrome A will be identified in approximately 1 in 200,000 Americans each year, and approximately 100,000 children currently suffer from syndrome B, whereas it is estimated that nearly 12,000 people died globally from syndrome C in 2020, and approximately 1% of people in the United States will develop disorder D during their lifetimes. Furthermore, according to the World Health Organization (WHO), a Switzerland-based United Nations agency responsible for international public health, in February 2022, birth abnormalities cause 240,000 new-borns to die in the first 28 days of life each year, and an additional 170,000 children between the ages of 1 month and 5 years die as a result of birth abnormalities, which include heart defects, neural tube defects, and Down syndrome (a genetic disorder). As a result, the rising prevalence of diseases and disorders with genetic transmission capabilities is propelling the direct-to-consumer (DTC) genetic testing market forward.

Request for A Sample Of The Global Direct To Consumer DTC Genetic Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

Key Direct To Consumer DTC Genetic Testing Market Trend – Technological Advancement
To maintain their market position, major companies in the direct-to-consumer (DTC) genetic testing market are focusing on developing technologically advanced solutions. For example, Superdrug Stores Plc, a UK-based health and beauty retailer, will launch CircleDNA, an advanced home DNA test kit that uses next-generation sequencing (NGS) technology, in March 2020. The new technology is capable of providing whole-exome sequencing, which can detect more than 90% of cancer mutations by measuring 31 million DNA positions per person. Furthermore, it provides test results such as cancer risk, illnesses, and brain health to discover actionable insights into their genetic blueprint, which can be critical for people and help them change their lifestyles for the better.

Direct To Consumer DTC Genetic Testing Market Segment
1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics, Other End-User

Direct To Consumer DTC Genetic Testing Market Major Players and Strategies
Major players in the direct to consumer DTC genetic testing market are 23andMe Holding Co., Ancestry.com LLC, Color Health Inc., EasyDNA, Full Genomes Corporation, Helix, Identigene LLC, Living DNA, MyHeritage Ltd., FamilyTreeDNA, Myriad Genetics Inc., Quest Diagnostics, Mapmygenome, Genesis HealthCare, Gene by Gene, Laboratory Corporation of America Holdings, Positive Bioscience, Sonora Quest Laboratories, Xcode Life Sciences Private Limited, 24Genetics, Konica Minolta Inc., Direct Laboratory Services LLC, Prenetics Global, Karmagenes, Pathway Genomics, Request A Test Ltd., Any Lab Test Now, Dante Labs, Fulgent Genetics, and Victorian Clinical Genetics Services.

LetsGetChecked, a virtual care company based in the United States that provides at-home testing, telehealth services, and pharmacy capabilities, acquired Veritas Genetics for an undisclosed sum in March 2022. LetsGetChecked intends to use this acquisition to launch a full lifecycle of personalised healthcare, offering the market’s most comprehensive range of health testing and care options. Veritas Genetics is a personal genomics biotechnology company based in the United States.

The Direct To Consumer DTC Genetic Testing Global Market Report 2023 covers regional data on direct to consumer DTC genetic testing market size, direct to consumer DTC genetic testing market trends and drivers, opportunities, strategies, and direct to consumer DTC genetic testing market competitor analysis. The countries covered in the direct to consumer DTC genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Direct-to-consumer genetic testing entails marketing genetic tests to consumers directly through media such as radio, television, print advertisements, and the internet, where customers can purchase the tests through online marketplaces and pharmacies. After purchasing a test kit, customers provide the company with a DNA sample and gain access to their genetic data without the involvement of a healthcare professional or health insurance provider via a secure website, app, or written report with their results.

View More Reports Related To The Direct To Consumer DTC Genetic Testing Market –
Genetically Modified Crops Global Market Report 2023
Genetic Testing Global Market Report 2023
Genetically Modified Fruits Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: